相关实验视频
Updated: May 27, 2025

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
289
中高风险肺栓塞的多种治疗方法:一个病例报告
Sandra OIiveira-Mendes1, Rafaela Lopes Freitas1, Joana Simões1
1Internal Medicine, Hospital Pedro Hispano, Matosinhos, PRT.
Cureus
|February 17, 2025
概括
在癌症患者中管理中高风险的肺栓塞 (PE) 需要平衡凝块去除与出血风险. 先进的干预和量身定制的血栓溶解改善了呼吸功能,但最终优先考虑的是息治疗.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
背景情况:
- 肺栓塞 (PE) 管理需要风险分层,特别是在没有血液动力学不稳定的中高风险病例中.
- 恶性病变是PE的重要危险因素,由于伴随疾病和出血风险,往往会使治疗复杂化.
研究的目的:
- 在患有晚期恶性瘤和高出血风险的患者中呈现复杂的中高风险PE病例.
- 为了说明管理这种病例的挑战和治疗策略,平衡血栓瘤解决与出血风险.
主要方法:
- 该病例涉及一名54岁的女性,患有恶性瘤相关的PE,严重的缺血性呼吸衰竭和高出血风险.
- 先进的干预包括穿皮血栓切除术,导管导向血栓溶解和减少剂量的全身血栓溶解,以MOPETT试验原则为指导.
主要成果:
- 经过多次先进的干预,患者在呼吸功能方面经历了显著的改善.
- 尽管PE的治疗成功,但晚期恶性瘤和病情下降导致人们转向息治疗.
结论:
- 对于复杂的PE病例来说,个性化治疗策略至关重要,它将急性血栓形成症的管理与患者的瘤学背景和生活质量相结合.
- 多学科合作对于优化PE,恶性瘤和并发症患者的治疗结果至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
145
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
145
Flail Chest-II
157
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
157
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
130
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
130
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
129
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
129
Anticoagulant Drugs: Low-Molecular-Weight Heparins
597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597
Pulmonary Tuberculosis V
168
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
168

